FCGR2A/FCGR3A gene polymorphisms and clinical variables as predictors of response to tocilizumab and rituximab in patients with rheumatoid arthritis
A Jiménez Morales… - The Journal of …, 2019 - Wiley Online Library
We evaluated the influence of clinical, biochemical, and genetic factors on response in 142
patients diagnosed with rheumatoid arthritis, of whom 87 patients were treated with …
patients diagnosed with rheumatoid arthritis, of whom 87 patients were treated with …
A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients
C Luxembourger, A Ruyssen-Witrand… - The …, 2019 - nature.com
Biological disease-modifying anti-rheumatic drugs (bDMARDs) have changed care of
patients with rheumatoid arthritis (RA). However, bDMARDs are costly, can lead to serious …
patients with rheumatoid arthritis (RA). However, bDMARDs are costly, can lead to serious …
Polimorfismos genéticos en FCGR3A y FCGR2A como marcadores de respuesta en las nuevas dianas terapéuticas en artritis reumatoide
A Jiménez Morales - 2019 - digibug.ugr.es
Los pacientes diagnosticados de AR en los que se inicia el tratamiento con TB se obtiene
una disparidad en la respuesta al tratamiento sin tener un conocimiento claro de qué …
una disparidad en la respuesta al tratamiento sin tener un conocimiento claro de qué …